Enhanced anticancer effect of MAP30–S3 by cyclosproin A through endosomal escape
Sign Up to like & getrecommendations! Published in 2018 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000000649
Abstract: Cyclosporin A (CsA) is a calcium antagonist and can enhance the efficacy of some protein drugs, but its mechanism remains unknown. In this study, MAP30, a ribosome-inactivating protein reported to have apoptotic effects on cancer… read more here.
Keywords: map30; effect; cancer; endosomal escape ... See more keywords